Enviaments recents

The microproteome of cancer: from invisibility to relevance

Merino Valverde, Iñaki; Greco, Emanuela; Abad Mendez, Maria (Data de publicació: 2021-11-11)

Càncer; Micropèptid; Supressors de tumors

Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in advanced non-small cell lung cancer

Salifu, Idoko; Singh, Navneet; Berraondo, Maria; Remon, Jordi; Salifu, Stephanie; Severson, Eric; Quintana, Angela; Peiró, Sandra (Data de publicació: 2023-05-22)

Antibody-drug conjugates, Immune-checkpoint inhibitors; Non-small cell lung cancer

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse

Bobillo Varela, Sabela; Joffe, Erel; Sermer, David; Mondello, Patrizia; Ghione, Paola; Caron, Philip C. (Data de publicació: 2022-02-25)

Limfoma de cèl·lules B; Supervivència lliure de malaltia

Genetic immune escape in cancer: timing and implications for treatment

Chowell, Diego; Martínez-Jiménez, Francisco (Data de publicació: 2025-04-22)

Immunotherapy resistance; Tumor evolution; Tumor microenvironment

Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer

Garazi, Serna; Cecchi, Fabiola; Fasani, Roberta; Thyparambil, Sheeno; Elez Fernandez, Mª Elena; Vivancos Prellezo, Ana; Tabernero Caturla, Josep; Nuciforo, Paolo Giovanni; Landolfi, Stefania; Ruiz Pace, Fiorella; Jimenez, Jose; Dienstmann, Rodrigo (Data de publicació: 2020-07-08)

Biomarcadores del cáncer; Cáncer metástico colorrectal; Terapias experimentales

Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial

Schoffski, Patrick; Heinrich, Michael; Jones, Robin; George, Suzanne; Gelderblom, Hans; von Mehren, Margaret; Serrano, Cesar (Data de publicació: 2024-02-22)

Ripretinib; Gastrointestinal stromal tumor; Biomarker

Decoding protein methylation function with thermal stability analysis

Sayago, Cristina; Sánchez-Wandelmer, Jana; Garcia-Martinez, Fernando; Hurtado, Begoña; Lafarga, Vanesa; Prieto, Patricia (Data de publicació: 2023-06-19)

Methylation; Proteomics

Immunotherapies against HER2-Positive Breast Cancer

Román Alonso, Macarena; Arribas López, Joaquin Vicente; Duro Sánchez, Santiago (Data de publicació: 2023-03-20)

Immunotherapy; Resistance; Vaccines

Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial

Preusser, Matthias; Garde-Noguera, Javier; GARCIA MOSQUERA, JUAN JOSE; Gion, María; Greil, Richard; Arumí De Dios, Míriam (Data de publicació: 2025-09-16)

Patritumab deruxtecan; Leptomeningeal metastatic disease; Solid tumors

A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignancies

Jiménez, Miguel Martín; Shimizu, Toshio; Keam, Bhumsuk; Rutten, Annemie; Curigliano, Giuseppe; Meric-Bernstam, Funda; GARRALDA, Elena (Data de publicació: 2024-10-22)

Tumors sòlids avançats

First-in-human study of FAZ053, an anti-programmed death-ligand 1 (anti-PD-L1) monoclonal antibody, alone and in combination with spartalizumab (anti-PD-1), in patients with advanced malignancies

Tan, David; Martín Liberal, Juan Jesús; Geva, Ravit; Gucalp, Ayca; Janku, Filip; Takahashi, Shunji (Data de publicació: 2025-07-10)

Advanced alveolar soft part sarcoma; Chordoma; Spartalizumab

Association of radiation-induced normal tissue toxicity with a high genetic risk for rheumatoid arthritis

Mcwilliam, Alan; Marshall, Deborah; Kerns, Sarah; Barnett, Gill; Vega, Ana; Kapouranis, Thodori; Gutiérrez-Enríquez, Sara (Data de publicació: 2025-07-10)

Toxicity; Radiation; Rheumatoid arthritis

miR-203 drives breast cancer cell differentiation

Martínez-Illescas, Nuria G.; Leal, Silvia; González, Patricia; Graña Castro, Osvaldo; Muñoz-Oliveira, Juan José; Cortés-Peña, Alfonso; Malumbres, Marcos (Data de publicació: 2023-08-30)

Breast cancer; Cell differentiation

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer

Kerzeli, Iliana K.; Kostakis, Alexandros; Turker, Polat; malmström, per-uno; Hemdan, Tammer; Mezheyeuski, Artur (Data de publicació: 2023-07-07)

Biomarkers; Proteomics; Urothelial bladder cancer

A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer

Sampayo-Cordero, Miguel; Miguel-Huguet, Bernat; Malfettone, Andrea; López-Miranda, Elena; Gion, María; Abad, Elena; Cortes, Javier (Data de publicació: 2023-08-30)

Clinical trial; Single-arm; Superiority

Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study

Petracci, Elisabetta; Pasini, Luigi; Urbini, Milena; stella, franco; Davoli, Fabio; FELIP, ENRIQUETA (Data de publicació: 2025-02-14)

MicroRNA; Extracellular vesicles; Prognostic biomarkers

Reporting reimbursement price decisions for onco-hematology drugs in Spain

Elvira-Martinez, David; Torres, Ferran; Puig, Gemma; Obach, Merce; Gay, Daniel; Vives, Roser; Tabernero, Josep (Data de publicació: 2023-11-21)

Health technology assessment; Onco-hematologic prices; Price and reimbursement systems

European screening platform for EORTC clinical trials in advanced colorectal cancer ‘SPECTAcolor’

Folprecht, Gunnar; Morfouace, Marie; Collienne, Maike; Salazar, Ramon; Stein, Alexander; Elez, Elena (Data de publicació: 2025-06-04)

Screening platform; Colorectal cancers; Targeted treatment

Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple‐negative breast cancer

Pascual Reguant, Laura; Serra Camprubí, Queralt; Datta, Debayan; Cianferoni, Damiano; Kourtis, Savvas; Gañez Zapater, Antoni; Miró Canturri, Andrea; Guzman Torres, Marta; Rodríguez, Olga; Querol, Jessica; Herencia Ropero, Andrea; Arribas, Joaquin; Serra, Violeta; TIAN, TIAN; Peiró, Sandra (Data de publicació: 2023-12-20)

Cell cycle; Gene expression; Triple-negative breast cancer

p27Kip1 V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor–positive breast cancer

Mouron, Silvana; Bueno, MJ; Muñoz, Manuel; Torres, Raul; Rodriguez, Sandra; Apala, Juan V.; Malumbres Martinez, Marcos (Data de publicació: 2023-04-25)

Biomarker; Hormone receptor-positive; Breast cancer

Sistema de Salut de Catalunya: Enviaments recents

The microproteome of cancer: from invisibility to relevance ﻿

Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in advanced non-small cell lung cancer ﻿

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse ﻿

Genetic immune escape in cancer: timing and implications for treatment ﻿

Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer ﻿

Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial ﻿

Decoding protein methylation function with thermal stability analysis ﻿

Immunotherapies against HER2-Positive Breast Cancer ﻿

Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial ﻿

A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignancies ﻿

First-in-human study of FAZ053, an anti-programmed death-ligand 1 (anti-PD-L1) monoclonal antibody, alone and in combination with spartalizumab (anti-PD-1), in patients with advanced malignancies ﻿

Association of radiation-induced normal tissue toxicity with a high genetic risk for rheumatoid arthritis ﻿

miR-203 drives breast cancer cell differentiation ﻿

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer ﻿

A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer ﻿

Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study ﻿

Reporting reimbursement price decisions for onco-hematology drugs in Spain ﻿

European screening platform for EORTC clinical trials in advanced colorectal cancer ‘SPECTAcolor’ ﻿

Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple‐negative breast cancer ﻿

p27Kip1 V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor–positive breast cancer ﻿